Goldman Sachs Put 100 ABT 20.09.2.../ DE000GG0YGH7 /
8/2/2024 9:07:58 AM | Chg.-0.030 | Bid7:21:13 PM | Ask7:21:13 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.060EUR | -33.33% | 0.067 Bid Size: 50,000 |
- Ask Size: - |
Abbott Laboratories | 100.00 USD | 9/20/2024 | Put |
GlobeNewswire
6/6
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors